RPG Life Sciences Ltd.
Snapshot View

673.05 +7.25 ▲1.1%

12 August 2022, 04:01:00 PM
Volume: 1,126

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.rpglifesciences.com
Market Cap 1,114.23 Cr.
Enterprise Value(EV) 1,044.55 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 33.93 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 19.86 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 165.66 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.07 Calculated using Price: 673.70
Dividend Yield 1.43 Period Ending 2022-03
No. of Shares Subscribed 1.65 Cr. 16,539,015 Shares
FaceValue 8
Company Profile
RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company's name was changed to RPG Life Sciences Ltd effective April 1, 1999.This company belongs to RPG group

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.09%
1 Week
+4.41%
1 Month
+14.96%
3 Month
+46.81%
6 Month
+16.81%
1 Year
+23.48%
2 Year
+78.13%
5 Year
+119.23%
10 Year
+821.99%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 52.87 0.80 8.98 14.98 8.91 6.86 17.21 20.36 21.80
Return on Capital Employed (%) 48.37 2.50 8.97 15.58 12.52 9.81 20.35 27.27 31.46
Return on Assets (%) 25.50 0.47 5.34 9.15 5.17 4.07 11.25 14.00 15.89

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 76 126 125 134 147 155 161 177 216 256
Non Curr. Liab. 22 7 20 22 11 8 10 9 7 9
Curr. Liab. 112 77 67 67 79 121 78 83 80 80
Minority Int.
Equity & Liab. 210 209 212 223 236 284 248 268 303 345
Non Curr. Assets 111 112 126 136 140 141 151 142 127 138
Curr. Assets 99 97 86 87 96 143 97 126 176 207
Misc. Exp. not W/O
Total Assets 210 209 212 223 236 284 248 268 303 345

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 236 242 279 294 344 330 376 389 440 461
Other Income 3 7 2 10 2 1 1 1 3 4
Total Income 238 249 281 303 346 331 377 390 443 465
Total Expenditure -224 -234 -257 -265 -307 -296 -316 -318 -353 -370
PBIDT 14 15 24 38 39 35 61 72 90 95
Interest -3 -3 -2 -4 -5 -5 -3 -2 -1 -1
Depreciation -11 -11 -10 -11 -14 -15 -16 -16 -16 -16
Taxation -12 -2 -7 -4 -7 -14 -22 -23
Exceptional Items 64 -5
PAT 53 1 12 21 13 11 29 40 51 56
Adjusted EPS 32 1 7 13 8 7 18 24 31 34

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 -6 -2 33 7 15 46 50 58 65
Cash Fr. Inv. -12 59 -10 -15 -30 -16 -19 -11 -8 -35
Cash Fr. Finan. 0 -54 12 -18 23 0 -27 -39 -10 -14
Net Change 0 0 0 1 -1 0 0 40 17
Cash & Cash Eqvt 0 0 0 0 1 0 0 1 40 57

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 72.07 72.07 72.07 72.07 72.07 72.07 72.07 72.07 72.41
Public 27.93 27.93 27.93 27.93 27.93 27.93 27.93 27.93 27.59
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 04 Aug 2022
Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended June 30 2022. Kindly take the same on record.
Wed, 03 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter ended June 30 2022.Kindly take this information on record.
Tue, 02 Aug 2022
Board Meeting Outcome for Outcome Of Board Meeting
In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company has at its meeting held on Tuesday August 02 2022 inter alia considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30 2022 along with Limited Review Report of the Statutory Auditors thereon.The meeting commenced at 03:00 p.m. and concluded at 06:00 p.m.Kindly take the same on your record.

Technical Scans View Details >>

Fri, 12 Aug 2022
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On RPG Life Sciences Ltd.

Can I Buy RPG Life Sciences Shares now?

What is the Share Price of RPG Life Sciences?

What is the Relative Strength Index (RSI) Value of RPG Life Sciences?

What is the Market Capital (MCAP) of RPG Life Sciences?

What are the key metrics to analyse RPG Life Sciences?

What is the Price Performance of RPG Life Sciences?